| Period Ending | Mar 30, 2013 | Dec 30, 2012 | Sep 29, 2012 | Jun 29, 2012 |
|---|
|
Total Revenue
|
91,938
|
92,433
|
80,472
|
81,015
| | Cost of Revenue | 42,892 | 42,896 | 39,789 | 35,072 | | |
Gross Profit
|
49,046
|
49,537
|
40,683
|
45,943
| |
|
Operating Expenses |
|
Research Development | 17,727 | 17,299 | 16,154 | 16,118 |
|
Selling General and Administrative | 30,999 | 27,180 | 30,197 | 27,764 |
|
Non Recurring |
-
|
-
| 15,110 |
-
|
|
Others |
-
|
-
|
-
|
-
|
|
|
|
Total Operating Expenses |
-
|
-
|
-
|
-
| | | |
Operating Income or Loss
|
320
|
5,058
|
(20,778)
|
2,061
| |
|
Income from Continuing Operations |
|
Total Other Income/Expenses Net | 408 | 275 | 185 | (566) |
|
Earnings Before Interest And Taxes | 694 | 5,333 | (20,593) | 1,506 |
|
Interest Expense |
-
| 34 | 96 | 17 |
|
Income Before Tax | 694 | 5,299 | (20,689) | 1,489 |
|
Income Tax Expense | 381 | (345) | 607 | 354 |
|
Minority Interest |
-
|
-
|
-
|
-
|
|
|
|
Net Income From Continuing Ops | 313 | 5,644 | (21,296) | 1,135 | |
|
Non-recurring Events |
|
Discontinued Operations |
-
|
-
|
-
|
-
|
|
Extraordinary Items |
-
|
-
|
-
|
-
|
|
Effect Of Accounting Changes |
-
|
-
|
-
|
-
|
|
Other Items |
-
|
-
|
-
|
-
| | | |
Net Income
|
313
|
5,644
|
(21,296)
|
1,135
| | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | |
Net Income Applicable To Common Shares
|
313
|
5,644
|
(21,296)
|
1,135
|
|
0.37(1.10%) 4:00PM EDT